Business combination (Tables)

12 Months Ended

Jul. 31, 2015

Pathfinder Therapeutics Inc

Summary of Estimated Fair Values of Separately Identifiable Assets Acquired and Liabilities Assumed

The following table summarizes the purchase price allocation based on the fair values of the separately identifiable assets acquired and liabilities assumed as of the acquisition date:

(in millions)
Inventory and receivables				$	0.2
Goodwill					0.4
Intangible assets:
Developed technology (estimated useful life of 10 years)	$	0.7
Customer relationships (estimated useful life of 2 years)		0.3
Trade names (estimated useful life of 5 years)		0.1
Total intangible assets					1.1
Total assets acquired					1.7
Accrued liabilities		(0.1	)
Total liabilities assumed					(0.1	)
Total purchase price				$	1.6

PocketSonics

Summary of Estimated Fair Values of Separately Identifiable Assets Acquired and Liabilities Assumed

The following table summarizes the fair values of the separately identifiable assets acquired and liabilities assumed as of September 20, 2013:

(in millions)
Cash				$	0.5
Goodwill					6.9
IPR&D					11.5
Total assets acquired					18.9
Accounts payable and accrued expenses	$	(0.3	)
Deferred taxes		(4.1	)
Total liabilities assumed					(4.4	)
Total purchase price				$	14.5